Full-Time

Quality Systems Engineer

Nudge

Nudge

11-50 employees

Non-invasive neuromodulation headset via ultrasound

No salary listed

San Francisco, CA, USA

In Person

Bachelor's

Category
Manufacturing Quality & Test (1)
Required Skills
Risk Management

Get referred to Nudge

See people who can refer or advise you

Requirements
  • At least 2 years of industry experience.
  • Experience with design controls, product and process validation, and risk management.
  • A degree in an engineering or scientific discipline, such as biomedical engineering, electrical engineering, or neuroscience, or equivalent hands-on experience.
  • Familiarity with Good Clinical Practice and human factors.
  • Familiarity with the FDA Quality Management System Regulation, ISO 13485, and ISO 14971.
  • Experience conducting risk management activities using tools such as failure mode and effects analysis.
  • Strong technical writing skills.
  • High integrity and strong professional judgment.
Responsibilities
  • Ensure that new and existing product designs and processes meet all internal and regulatory requirements for safety and performance.
  • Partner in new product development by leading quality-critical discussions, influencing key decisions, and driving necessary process changes across design controls, investigational studies, and clinical trials.
  • Manage multiple tasks and drive execution of change orders.
  • Initiate or support corrective and preventive actions and non-conformances, lead investigations, and implement mitigations.
  • Represent and cultivate a culture of quality by working with interdisciplinary teams to set expectations, identify gaps, and meet a high internal standard for rigor.

Generate a concise company summary answering: 1) what the company does, 2) how its product works, 3) how it differs from competitors, 4) its goal, based on the provided description.

Company Size

11-50

Company Stage

Series A

Total Funding

$100M

Headquarters

San Francisco, California

Founded

2025

Get referred to Nudge

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 2025 funding gave Nudge capital for trials and device iteration.
  • Current studies are enrolling for essential tremor, chronic pain, tinnitus, and healthy volunteers.
  • Patient applications are planned soon, expanding from research toward clinical revenue.

What critics are saying

  • Nudge still runs feasibility studies, not treatment studies, for chronic pain and SUD.
  • Regulators can halt ultrasound brain claims before commercialization in 2026.
  • If safety or efficacy fails, Nudge becomes an expensive research platform, not a product.

What makes Nudge unique

  • Focused ultrasound lets Nudge stimulate and image brain tissue without surgery.
  • July 2025 Series A from Thrive Capital and Greenoaks validates the platform.
  • Nudge Zero reached human-ready testing within months, showing rare execution speed.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

2%

2 year growth

18%
Equity Bulls
Aug 12th, 2025
FSN E-Commerce acquires 40% Nudge stake

FSN E-Commerce Ventures Ltd has approved the acquisition of the remaining 40% stake in Nudge Wellness Pvt Ltd from Onesto Labs Pvt Ltd, as per the terms of a shareholders' agreement from April 2022. Onesto will no longer hold any stake in Nudge post-transaction. FSN's stock traded at ₹203.60 on BSE, with a high of ₹204.25 and a low of ₹200.25, and a net turnover of ₹9.53 million.

Dealroom.co
Jul 26th, 2025
Nudge company information, funding & investors

Nudge, non-invasive neuromodulation headset enhancing brain function through precise stimulation and imaging. Here you'll find information about their funding, investors and team.

Nudge
Jul 25th, 2025
Announcing Nudge's $100M Series A Fundraise

Nudge - Whole-brain interfaces for everyday life